Caricamento...
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
More than 2000 immuno-oncology agents are being tested or are in use as a result of the cancer immunotherapy revolution. Manipulation of co-inhibitory receptors has achieved tumor eradication in a minority of patients, but widespread immune-related adverse events (irAEs) compromised tolerance to hea...
Salvato in:
| Pubblicato in: | Cancer Immunol Immunother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183506/ https://ncbi.nlm.nih.gov/pubmed/32152702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02543-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|